A potential contribution of antimicrobial peptide LL-37 to tissue fibrosis and vasculopathy in systemic sclerosis-Reference-Cited by-同舟云学术

A potential contribution of antimicrobial peptide LL-37 to tissue fibrosis and vasculopathy in systemic sclerosis

Published:2016-08-30 Issue:6 Volume:175 Page:1195-1203
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:Br J Dermatol

Author:

Takahashi T.¹,Asano Y.¹,Nakamura K.¹,Yamashita T.¹,Saigusa R.¹,Ichimura Y.¹,Toyama T.¹,Taniguchi T.¹,Yoshizaki A.¹,Tamaki Z.¹,Tada Y.¹,Sugaya M.¹,Kadono T.¹,Sato S.¹

Affiliation:

1. Department of Dermatology; University of Tokyo Graduate School of Medicine; 7-3-1 Hongo Bunkyo-ku, Tokyo 113-8655 Japan

Funder

Ministry of Health, Labour and Welfare

Publisher

Wiley

Subject

Dermatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjd.14699/fullpdf

Reference42 articles.

1. Future treatments in systemic sclerosis;Asano;J Dermatol,2010

2. Little peptide, big effects: the role of LL-37 in inflammation and autoimmune disease;Kahlenberg;J Immunol,2013

3. Kallikrein-mediated proteolysis regulates the antimicrobial effects of cathelicidins in skin;Yamasaki;FASEB J,2006

4. LL-37 suppresses sodium nitroprusside-induced apoptosis of systemic sclerosis dermal fibroblasts;Kim;Exp Dermatol,2011

5. Decrease of LL-37 in systemic sclerosis: a new marker for interstitial lung disease?;Hizal;Clin Rheumatol,2015

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. FLI-1-driven regulation of endothelial cells in human diseases;Journal of Translational Medicine;2024-08-06

2. Discovery of novel antibacterial agent for the infected wound treatment: all-hydrocarbon stapling optimization of LL-37;Theranostics;2024

3. Cathelicidin LL-37 expression in human breast implant capsules;Plastic & Reconstructive Surgery;2023-05-22

4. The Antimicrobial Peptide Cathelicidin Exerts Immunomodulatory Effects via Scavenger Receptors;International Journal of Molecular Sciences;2023-01-03

5. Fli1 deficiency suppresses RALDH1 activity of dermal dendritic cells and related induction of regulatory T cells: a possible role in scleroderma;Arthritis Research & Therapy;2021-05-08